Baker Biotech Capital (Gp), Llc
Affiliations
- Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2012-03-09
- Large Shareholder at Xoma Corp (XOMA), 2012-03-09
- Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
- Large Shareholder, Director at Synageva Biopharma Corp (GEVA), 2012-01-10
- Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2012-01-05
- Large Shareholder at Adolor Corp (ADLR), 2012-01-03
- Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
- Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
- Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
- Large Shareholder, Director at Incyte Corp (INCY), 2010-09-23
- Large Shareholder at Vaxgen Inc (VXGN.OB), 2010-07-29
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2009-06-01
- Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| TZYM | $3.01 | 4,592 | $13,801.26 | 232,011 | 2012-03-14 | Filing |
| TZYM | $2.99 | 7,484 | $22,370.42 | 227,419 | 2012-03-14 | Filing |
| TZYM | $2.96 | 15,599 | $46,143.40 | 219,935 | 2012-03-13 | Filing |
| TZYM | $2.55 | 56,187 | $143,276.85 | 204,336 | 2012-03-12 | Filing |
| TZYM | $2.34 | 32,155 | $75,229.84 | 148,149 | 2012-03-12 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AUXL | $17.25 | 6,361 | $109,714.53 | 844,839 | 2011-08-02 | Filing |
| AUXL | $18.04 | 61,519 | $1,109,735.09 | 851,200 | 2011-08-01 | Filing |
| AUXL | $18.03 | 40,690 | $733,620.36 | 912,719 | 2011-08-01 | Filing |
| ADLR | $1.18 | 376 | $444.81 | 79,054 | 2010-10-29 | Filing |
| ADLR | $1.19 | 885 | $1,051.73 | 79,430 | 2010-10-28 | Filing |